Skip to main content
SpringerLink
Log in

Milestones in the field of tumor microenvironment—Contributions & perspectives of Prof. Isaac P. Witz

  • Commentary
  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zipin A, et al., Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Cancer Res, 64(18): 6571–6578, 2004

    Article  PubMed  Google Scholar 

  2. Levy-Nissenbaum O, et al., cDNA microarray analysis reveals an overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia. Methods Enzymol, 366: 103–113, 2003

    PubMed  Google Scholar 

  3. Witz IP: The tumour microenvironment—Introduction. Semin Cancer Biol 12: 87–88, 2002

    Article  PubMed  Google Scholar 

  4. Eshel R, et al., Receptors involved in microenvironment-driven molecular evolution of cancer cells. Semin Cancer Biol, 12(2): 139–147, 2002

    PubMed  Google Scholar 

  5. Witz IP: Presence and functions of immune components in the tumor microenvironment. Adv Exp Med Biol, 495: p. 317–324, 2001

    PubMed  Google Scholar 

  6. Witz IP: Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins. J Cell Biochem Suppl, 34: 61–66, 2000

    PubMed  Google Scholar 

  7. Witz IP: The shaping of a malignancy phenotype by microenvironmental host factors. In: Recent Advances in Gastroenterological Carcinogenesis. I.F. Tahara, K. Sugimachi and T. Oohara, Eds. Monduzzi Editore Bologna, 287–294, 1996

  8. Witz IP, Sagi-Assif, O, Ran, M: The shaping of the malignancy phenotype—an interplay between cellular characteristics and microenvironmental factors. In: Premalignancy and Tumor Dormancy. (Eitan Yefenof and Richard H. Scheuermann, Eds.). Medical Intelligence Unit, R.G. Landes Co., 147–156, 1996

  9. Witz IP, Ran, M: Could Fc-Receptors facilitate the escape of immunogenic premalignant cells from host defence? A hypothesis. Ann. Inst. Pasteur 136C: 423–428, 1985

    Google Scholar 

  10. Ran M, Witz, IP: The significance of tumor associated anti T cell antibodies for tumor-host immune relationship. Leukemia Rev., 2: 151–171, 1984

    Google Scholar 

  11. Russell SW, Witz IP, Herberman RB: A review of data, problems, and open questions pertaining to in situ tumor immunity. Contemp Top Immunobiol 10: p. 1–20, 1980

    PubMed  Google Scholar 

  12. Ran M, et al., Tumor-localizing lymphocytotoxic antibodies. Contemp Top Immunobiol, 10: 191–211, 1980

    PubMed  Google Scholar 

  13. Witz IP: Tumor-bound immunoglobulins: in situ expressions of humoral immunity. Adv Cancer Res 25: 95–148, 1977

    PubMed  Google Scholar 

  14. Witz IP: The biological significance of tumor-bound immunoglobulins. Curr Top Microbiol Immunol 61: 151–71, 1973

    PubMed  Google Scholar 

  15. Witz IP: Tumor-associated immunoglobulins. Isr J Med Sci 1971. 7(1): 230–238

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Department of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel Aviv, 69978, Israel

    Orlev Levy-Nissenbaum Ph.D.

Authors
  1. Orlev Levy-Nissenbaum Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy-Nissenbaum, O. Milestones in the field of tumor microenvironment—Contributions & perspectives of Prof. Isaac P. Witz. Cancer Metastasis Rev 24, 469–472 (2005). https://doi.org/10.1007/s10555-005-5136-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-005-5136-1

Keywords

Search

Navigation